Pictet Asset Management (Switzerland)’s Novavax NVAX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$76.7K	Hold	10,322	–	–	﹤0.01%	1907
2023 Q1	$71.5K	Sell	10,322 -113,871	-92%	-$1.05M	﹤0.01%	1917
2022 Q4	$1.28M	Buy	124,193 +41,506	+50%	+$732K	﹤0.01%	979
2022 Q3	$1.5M	Buy	82,687 +19,675	+31%	+$853K	﹤0.01%	966
2022 Q2	$3.24M	Sell	63,012 -536,943	-89%	-$27.8M	﹤0.01%	852
2022 Q1	$44.2M	Buy	599,955 +68,438	+13%	+$6.1M	0.05%	335
2021 Q4	$76M	Sell	531,517 -12,389	-2%	-$2.13M	0.08%	271
2021 Q3	$113M	Buy	+543,906	New	+$120M	0.12%	211

Other funds holding NVAX

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s NVAX Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) held its Novavax (NVAX) position steady in Q2 2023 at 10,322 shares worth $76.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1907.

Pictet Asset Management (Switzerland) first reported a position in NVAX in Q3 2021 and has held it in 8 quarters since. The position peaked at $113M in Q3 2021. 216 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.

Pictet Asset Management (Switzerland) held 10,322 shares of Novavax worth $76.7K as of Q2 2023.
Pictet Asset Management (Switzerland) left its Novavax share count unchanged in Q2 2023.
Novavax made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1907 holding.
Pictet Asset Management (Switzerland) first reported a position in Novavax in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Novavax position peaked at $113M in Q3 2021.
216 funds tracked by Wall St. Rank held Novavax as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.